Literature DB >> 6813858

Autoantibodies occurring in two different rheumatic diseases react with the same nuclear ribonucleoprotein particle.

A S Douvas.   

Abstract

Patients affected with systemic lupus erythematosus and mixed connective tissue disease produce antibodies directed against two nuclear antigens, Sm and nuclear ribonucleoprotein (nRNP), respectively. The two antigens exhibit a relationship of partial identity in serologic assays, but the molecular basis of this relationship was not understood. This report describes the isolation of a nRNP particle containing both nRNP and Sm antigens. The particle was isolated by sucrose density gradient centrifugation of a rat liver nuclear extract followed by anti-nRNP affinity chromatography of a 14S gradient fraction. The protein moiety of the isolated particle consisted primarily of two polypeptides, P13 (Mr, 13,000) and P30 (Mr, 30,000). The immunoreactivity of P13 and P30 was demonstrated directly by transfer of these proteins from gels to nitrocellulose paper, followed by immunoautoradiography. Anti-nRNP sera reacted only with P30, whereas anti-Sm sera reacted with P13. Anti-nRNP sera were previously found to react with P13, but only in the presence of RNA [Douvas, A. S., Stumph, W. E., Reyes, P. R. & Tan, E. M. (1979) J. Biol. Chem. 254, 3608--3616]. From these observations it was concluded that P13 is the Sm antigen. The precipitating nRNP antigen is composed of P30--RNA complexes or P13--RNA complexes, with a RNA-independent reaction occurring with P30. The partial identity between Sm and nRNP antigens can be explained on the basis of a common reactivity to the P30--P13--RNA particle, with anti-Sm sera capable of binding additionally to RNA-free P13.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813858      PMCID: PMC346905          DOI: 10.1073/pnas.79.17.5401

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Profiles of antinuclear antibodies in systemic rheumatic diseases.

Authors:  D D Notman; N Kurata; E M Tan
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

2.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.

Authors:  N Kurata; E M Tan
Journal:  Arthritis Rheum       Date:  1976 May-Jun

3.  Histones H2a, H2b, H3, and H4 form a tetrameric complex in solutions of high salt.

Authors:  H Weintraub; K Palter; F Van Lente
Journal:  Cell       Date:  1975-09       Impact factor: 41.582

4.  Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma.

Authors:  A S Douvas; M Achten; E M Tan
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

5.  Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease.

Authors:  M D Parker
Journal:  J Lab Clin Med       Date:  1973-11

6.  Polypeptides of the tail fibres of bacteriophage T4.

Authors:  J King; U K Laemmli
Journal:  J Mol Biol       Date:  1971-12-28       Impact factor: 5.469

7.  A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250.

Authors:  J J Sedmak; S E Grossberg
Journal:  Anal Biochem       Date:  1977-05-01       Impact factor: 3.365

8.  Isolation and characterization of nuclear ribonucleoprotein complexes using human anti-nuclear ribonucleoprotein antibodies.

Authors:  A S Douvas; W E Stumph; P Reyes; E M Tan
Journal:  J Biol Chem       Date:  1979-05-10       Impact factor: 5.157

9.  Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.

Authors:  G C Sharp; W S Irvin; C M May; H R Holman; F C McDuffie; E V Hess; F R Schmid
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

10.  Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.

Authors:  E M Tan; H G Kunkel
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

View more
  5 in total

1.  Antibodies to heterogeneous nuclear ribonucleoproteins in sera from patients with rheumatic autoimmune diseases.

Authors:  M Zouali; A Eyquem
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

2.  Synthesis and assembly of human small nuclear ribonucleoproteins generated by cell-free translation.

Authors:  D E Fisher; G E Conner; W H Reeves; G Blobel; H G Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

3.  Polypeptide components of human small nuclear ribonucleoproteins.

Authors:  J C Wooley; L R Zukerberg; S Y Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

4.  Clinical significance of IgG subclasses of Anti-Sm and U1 ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease.

Authors:  Y Tokano; M Yasuma; S Harada; Y Takasaki; H Hashimoto; K Okumura; S Hirose
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

Review 5.  Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.

Authors:  Mandy Sowa; Rico Hiemann; Peter Schierack; Dirk Reinhold; Karsten Conrad; Dirk Roggenbuck
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.